Grifols is a global pharmaceutical company developing, manufacturing and distributing a range of biological medicines based on plasma derived proteins. Co. organizes its business into several divisions, including: Bioscience, which includes activities relating to the manufacture of plasma derivatives for therapeutic use, and the sale and distribution of end products; Diagnostic, which focuses on researching, developing, manufacturing and marketing in vitro diagnostics products; Hospital, which provides technology and services for hospitals, clinics and other centers for the manufacture of medicines; and Bio Supplies, which primarily consists of biological products for non-therapeutic use.